Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

Clinical trial NCT06817889 · RECRUITING

Trial details

NCT number: NCT06817889
Sponsor: Fred Hutchinson Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hematopoietic and Lymphatic System Neoplasm Autoimmune Disease Respiratory Syncytial Virus Infection

Start date: 2025-12-23
Primary completion: 2027-11-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.